Long-term follow-up after combined fissurectomy and Botox injection for chronic anal fissures

Chronic anal fissures are difficult to treat. The aim of this retrospective study was to determine the outcome of combined fissurectomy and injection of botulinum toxin Type A (BT). Between January 2001 and August 2004, 40 patients (21 women), median age 37 years (range 18 to 57), underwent fissurec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of colorectal disease 2007-09, Vol.22 (9), p.1077-1081
Hauptverfasser: SCHOLZ, Th, HETZER, F. H, DINDO, D, DEMARTINES, N, CLAVIEN, P. A, HAHNLOSER, D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1081
container_issue 9
container_start_page 1077
container_title International journal of colorectal disease
container_volume 22
creator SCHOLZ, Th
HETZER, F. H
DINDO, D
DEMARTINES, N
CLAVIEN, P. A
HAHNLOSER, D
description Chronic anal fissures are difficult to treat. The aim of this retrospective study was to determine the outcome of combined fissurectomy and injection of botulinum toxin Type A (BT). Between January 2001 and August 2004, 40 patients (21 women), median age 37 years (range 18 to 57), underwent fissurectomy and BT injection. Fissurectomy was performed followed by injection of 10 U of BT into the internal anal sphincter on both sides of the fissure. All patients were clinically checked 6 weeks after the operation. At 1 year, patients were sent a detailed questionnaire regarding symptoms, recurrence and further treatment for evaluation of long-term results. At 6 weeks, 38 patients (95%) were free of symptoms. No adverse effects were detected. The response rate of questionnaires was 93%; the median follow-up was 1 year (range 0.9 to 1.6). In the long-term, a recurrence was found in four patients. These patients were treated successfully with repeated fissurectomy and BT injections and salvage procedures, respectively. Overall, the success rate of combined fissurectomy and BT injection was 79%. Combined fissurectomy and Botox injection for chronic anal fissure is an excellent and safe procedure with low morbidity and a high healing rate.
doi_str_mv 10.1007/s00384-006-0261-z
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_216526280</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1344063271</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-c73967ba138010a4e866d9466d78769e1b55df1196985b6888b78ea1aeae60183</originalsourceid><addsrcrecordid>eNpFkMtKAzEUhoMotlYfwI0MgsvoOXPJZanFGxTc6FJCJpPRKTOTmsyg7dOb0oqbhJx8_0_yEXKOcI0A_CYAZCKnAIxCypBuDsgU8yylmLL0kEwBuaQoCzEhJyEsIZ4Zz4_JBHkEUkin5H3h-g86WN8ltWtb903HVaLrOEiM68qmt1VSNyGM3prBdetE91Vy5wb3kzT9Ms4a18dkpD-96xsT73X7lwin5KjWbbBn-31G3h7uX-dPdPHy-Dy_XVCTSTlQwzPJeKkxE4CgcysYq2QeFy44kxbLoqhqRMmkKEomhCi5sBq11ZYBimxGLne9K---RhsGtXSjjy8JKkVWxM8KiBDuIONdCN7WauWbTvu1QlBbn2rnU0WfautTbWLmYl88lp2t_hN7gRG42gM6GN3WXvemCf-ckPm2OvsF_cl9kQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216526280</pqid></control><display><type>article</type><title>Long-term follow-up after combined fissurectomy and Botox injection for chronic anal fissures</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>SCHOLZ, Th ; HETZER, F. H ; DINDO, D ; DEMARTINES, N ; CLAVIEN, P. A ; HAHNLOSER, D</creator><creatorcontrib>SCHOLZ, Th ; HETZER, F. H ; DINDO, D ; DEMARTINES, N ; CLAVIEN, P. A ; HAHNLOSER, D</creatorcontrib><description>Chronic anal fissures are difficult to treat. The aim of this retrospective study was to determine the outcome of combined fissurectomy and injection of botulinum toxin Type A (BT). Between January 2001 and August 2004, 40 patients (21 women), median age 37 years (range 18 to 57), underwent fissurectomy and BT injection. Fissurectomy was performed followed by injection of 10 U of BT into the internal anal sphincter on both sides of the fissure. All patients were clinically checked 6 weeks after the operation. At 1 year, patients were sent a detailed questionnaire regarding symptoms, recurrence and further treatment for evaluation of long-term results. At 6 weeks, 38 patients (95%) were free of symptoms. No adverse effects were detected. The response rate of questionnaires was 93%; the median follow-up was 1 year (range 0.9 to 1.6). In the long-term, a recurrence was found in four patients. These patients were treated successfully with repeated fissurectomy and BT injections and salvage procedures, respectively. Overall, the success rate of combined fissurectomy and BT injection was 79%. Combined fissurectomy and Botox injection for chronic anal fissure is an excellent and safe procedure with low morbidity and a high healing rate.</description><identifier>ISSN: 0179-1958</identifier><identifier>EISSN: 1432-1262</identifier><identifier>DOI: 10.1007/s00384-006-0261-z</identifier><identifier>PMID: 17262202</identifier><identifier>CODEN: IJCDE6</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Adolescent ; Adult ; Biological and medical sciences ; Botulinum Toxins, Type A - adverse effects ; Botulinum Toxins, Type A - therapeutic use ; Chronic Disease ; Drug Therapy, Combination ; Female ; Fissure in Ano - drug therapy ; Fissure in Ano - surgery ; Follow-Up Studies ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Male ; Medical sciences ; Middle Aged ; Neuromuscular Agents - therapeutic use ; Other diseases. Semiology ; Retrospective Studies ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Treatment Outcome ; Wound Healing - drug effects</subject><ispartof>International journal of colorectal disease, 2007-09, Vol.22 (9), p.1077-1081</ispartof><rights>2007 INIST-CNRS</rights><rights>Springer-Verlag 2007</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-c73967ba138010a4e866d9466d78769e1b55df1196985b6888b78ea1aeae60183</citedby><cites>FETCH-LOGICAL-c399t-c73967ba138010a4e866d9466d78769e1b55df1196985b6888b78ea1aeae60183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18941007$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17262202$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SCHOLZ, Th</creatorcontrib><creatorcontrib>HETZER, F. H</creatorcontrib><creatorcontrib>DINDO, D</creatorcontrib><creatorcontrib>DEMARTINES, N</creatorcontrib><creatorcontrib>CLAVIEN, P. A</creatorcontrib><creatorcontrib>HAHNLOSER, D</creatorcontrib><title>Long-term follow-up after combined fissurectomy and Botox injection for chronic anal fissures</title><title>International journal of colorectal disease</title><addtitle>Int J Colorectal Dis</addtitle><description>Chronic anal fissures are difficult to treat. The aim of this retrospective study was to determine the outcome of combined fissurectomy and injection of botulinum toxin Type A (BT). Between January 2001 and August 2004, 40 patients (21 women), median age 37 years (range 18 to 57), underwent fissurectomy and BT injection. Fissurectomy was performed followed by injection of 10 U of BT into the internal anal sphincter on both sides of the fissure. All patients were clinically checked 6 weeks after the operation. At 1 year, patients were sent a detailed questionnaire regarding symptoms, recurrence and further treatment for evaluation of long-term results. At 6 weeks, 38 patients (95%) were free of symptoms. No adverse effects were detected. The response rate of questionnaires was 93%; the median follow-up was 1 year (range 0.9 to 1.6). In the long-term, a recurrence was found in four patients. These patients were treated successfully with repeated fissurectomy and BT injections and salvage procedures, respectively. Overall, the success rate of combined fissurectomy and BT injection was 79%. Combined fissurectomy and Botox injection for chronic anal fissure is an excellent and safe procedure with low morbidity and a high healing rate.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Botulinum Toxins, Type A - adverse effects</subject><subject>Botulinum Toxins, Type A - therapeutic use</subject><subject>Chronic Disease</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Fissure in Ano - drug therapy</subject><subject>Fissure in Ano - surgery</subject><subject>Follow-Up Studies</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neuromuscular Agents - therapeutic use</subject><subject>Other diseases. Semiology</subject><subject>Retrospective Studies</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Treatment Outcome</subject><subject>Wound Healing - drug effects</subject><issn>0179-1958</issn><issn>1432-1262</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpFkMtKAzEUhoMotlYfwI0MgsvoOXPJZanFGxTc6FJCJpPRKTOTmsyg7dOb0oqbhJx8_0_yEXKOcI0A_CYAZCKnAIxCypBuDsgU8yylmLL0kEwBuaQoCzEhJyEsIZ4Zz4_JBHkEUkin5H3h-g86WN8ltWtb903HVaLrOEiM68qmt1VSNyGM3prBdetE91Vy5wb3kzT9Ms4a18dkpD-96xsT73X7lwin5KjWbbBn-31G3h7uX-dPdPHy-Dy_XVCTSTlQwzPJeKkxE4CgcysYq2QeFy44kxbLoqhqRMmkKEomhCi5sBq11ZYBimxGLne9K---RhsGtXSjjy8JKkVWxM8KiBDuIONdCN7WauWbTvu1QlBbn2rnU0WfautTbWLmYl88lp2t_hN7gRG42gM6GN3WXvemCf-ckPm2OvsF_cl9kQ</recordid><startdate>20070901</startdate><enddate>20070901</enddate><creator>SCHOLZ, Th</creator><creator>HETZER, F. H</creator><creator>DINDO, D</creator><creator>DEMARTINES, N</creator><creator>CLAVIEN, P. A</creator><creator>HAHNLOSER, D</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>20070901</creationdate><title>Long-term follow-up after combined fissurectomy and Botox injection for chronic anal fissures</title><author>SCHOLZ, Th ; HETZER, F. H ; DINDO, D ; DEMARTINES, N ; CLAVIEN, P. A ; HAHNLOSER, D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-c73967ba138010a4e866d9466d78769e1b55df1196985b6888b78ea1aeae60183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Botulinum Toxins, Type A - adverse effects</topic><topic>Botulinum Toxins, Type A - therapeutic use</topic><topic>Chronic Disease</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Fissure in Ano - drug therapy</topic><topic>Fissure in Ano - surgery</topic><topic>Follow-Up Studies</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neuromuscular Agents - therapeutic use</topic><topic>Other diseases. Semiology</topic><topic>Retrospective Studies</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Treatment Outcome</topic><topic>Wound Healing - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SCHOLZ, Th</creatorcontrib><creatorcontrib>HETZER, F. H</creatorcontrib><creatorcontrib>DINDO, D</creatorcontrib><creatorcontrib>DEMARTINES, N</creatorcontrib><creatorcontrib>CLAVIEN, P. A</creatorcontrib><creatorcontrib>HAHNLOSER, D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>International journal of colorectal disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SCHOLZ, Th</au><au>HETZER, F. H</au><au>DINDO, D</au><au>DEMARTINES, N</au><au>CLAVIEN, P. A</au><au>HAHNLOSER, D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term follow-up after combined fissurectomy and Botox injection for chronic anal fissures</atitle><jtitle>International journal of colorectal disease</jtitle><addtitle>Int J Colorectal Dis</addtitle><date>2007-09-01</date><risdate>2007</risdate><volume>22</volume><issue>9</issue><spage>1077</spage><epage>1081</epage><pages>1077-1081</pages><issn>0179-1958</issn><eissn>1432-1262</eissn><coden>IJCDE6</coden><abstract>Chronic anal fissures are difficult to treat. The aim of this retrospective study was to determine the outcome of combined fissurectomy and injection of botulinum toxin Type A (BT). Between January 2001 and August 2004, 40 patients (21 women), median age 37 years (range 18 to 57), underwent fissurectomy and BT injection. Fissurectomy was performed followed by injection of 10 U of BT into the internal anal sphincter on both sides of the fissure. All patients were clinically checked 6 weeks after the operation. At 1 year, patients were sent a detailed questionnaire regarding symptoms, recurrence and further treatment for evaluation of long-term results. At 6 weeks, 38 patients (95%) were free of symptoms. No adverse effects were detected. The response rate of questionnaires was 93%; the median follow-up was 1 year (range 0.9 to 1.6). In the long-term, a recurrence was found in four patients. These patients were treated successfully with repeated fissurectomy and BT injections and salvage procedures, respectively. Overall, the success rate of combined fissurectomy and BT injection was 79%. Combined fissurectomy and Botox injection for chronic anal fissure is an excellent and safe procedure with low morbidity and a high healing rate.</abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><pmid>17262202</pmid><doi>10.1007/s00384-006-0261-z</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0179-1958
ispartof International journal of colorectal disease, 2007-09, Vol.22 (9), p.1077-1081
issn 0179-1958
1432-1262
language eng
recordid cdi_proquest_journals_216526280
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adolescent
Adult
Biological and medical sciences
Botulinum Toxins, Type A - adverse effects
Botulinum Toxins, Type A - therapeutic use
Chronic Disease
Drug Therapy, Combination
Female
Fissure in Ano - drug therapy
Fissure in Ano - surgery
Follow-Up Studies
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Male
Medical sciences
Middle Aged
Neuromuscular Agents - therapeutic use
Other diseases. Semiology
Retrospective Studies
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Treatment Outcome
Wound Healing - drug effects
title Long-term follow-up after combined fissurectomy and Botox injection for chronic anal fissures
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T00%3A03%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20follow-up%20after%20combined%20fissurectomy%20and%20Botox%20injection%20for%20chronic%20anal%20fissures&rft.jtitle=International%20journal%20of%20colorectal%20disease&rft.au=SCHOLZ,%20Th&rft.date=2007-09-01&rft.volume=22&rft.issue=9&rft.spage=1077&rft.epage=1081&rft.pages=1077-1081&rft.issn=0179-1958&rft.eissn=1432-1262&rft.coden=IJCDE6&rft_id=info:doi/10.1007/s00384-006-0261-z&rft_dat=%3Cproquest_cross%3E1344063271%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216526280&rft_id=info:pmid/17262202&rfr_iscdi=true